Jain Global’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
AVLSA
OAG
VCM
PA
FIS
Jain Global's DYN Position: Q1 2026 in Review
Jain Global sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 162,047 shares — an estimated $3.17M sold.
Jain Global first reported a position in DYN in Q2 2025 and held it in 3 quarters. The position peaked at $8.15M in Q3 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.
- Jain Global reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
- Jain Global sold 162,047 Dyne Therapeutics shares in Q1 2026, an estimated $3.17M.
- Jain Global first reported a position in Dyne Therapeutics in Q2 2025 and held it in 3 quarters.
- Jain Global's Dyne Therapeutics position peaked at $8.15M in Q3 2025.
- 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.
Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.